Hungry for relief: Potential for neurotensin to address comorbid obesity and pain.

Chronic pain and obesity frequently occur together. An ideal therapy would alleviate pain without weight gain, and most optimally, could promote weight loss. The neuropeptide neurotensin (Nts) has been separately implicated in reducing weight and pain but could it be a common actionable target for both pain and obesity? Here we review the current knowledge of Nts signaling via its receptors in modulating body weight and pain processing. Evaluating the mechanism by which Nts impacts ingestive behavior, body weight, and analgesia has potential to identify common physiologic mechanisms underlying weight and pain comorbidities, and whether Nts may be common actionable targets for both.
Competing Interests: Declaration of competing interest None of the authors have any conflicts of interest related to this work.
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)